Early Sirolimus Therapy Combined With Sclerotherapy for the Management of Extensive Neonatal Cervicofacial Lymphatic Malformations: Clinical and MR-Volumetric Follow-up in a Series of 10 Patients
Antoine Fraissenon(Université Claude Bernard Lyon 1), Laurent Guibaud(Hospices Civils de Lyon), Loïc Viremouneix(Université Claude Bernard Lyon 1), A Guilhem(Inserm), Sara Cabet(Hôpital Femme Mère Enfant), M. Bigorre(Société Française de Médecine Vasculaire), Julie Chauvel Picard(Université Claude Bernard Lyon 1), Gabriel Morin(Inserm), Alexandre Belot(Université Claude Bernard Lyon 1), Guillaume Canaud(Inserm), Francis Fortin(Université Claude Bernard Lyon 1), Olivier Dunand(Hôpital Nord), Fernanda Frade(Hôpital Nord), I Quéré(Société Française de Médecine Vasculaire)
Cited by 0
Related Papers
Estrogen Permits Vasopressin Signaling in Preoptic Kisspeptin Neurons in the Female Mouse
|Journal of Neuroscience|2015|94
Alpelisib administration reduced lymphatic malformations in a mouse model and in patients
|Science Translational Medicine|2021|92
Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib
|The Journal of Experimental Medicine|2022|73
Sotorasib for Vascular Malformations Associated with <i>KRAS</i> G12C Mutation
|New England Journal of Medicine|2024|38